Related by context. All words. (Click for frequent words.) 57 Logo http:/www.newscom.com/cgi-bin/prnh/#/Champions Crowned 53 Aruvian Research 50 Metabolic Endocrinology 49 Therapeutic Competitors 49 Biodegradable Polymers 49 Aruvian R'search presents 49 Researchs 48 PharmaVitae 47 PharmaVitae Profile 47 Solar Photovoltaic Market 47 Ltd Therapeutic Competitors 47 Competitor Analysis 47 Detailed Product 46 Partnering Agreements 46 Therapeutic Competitors companiesandmarkets.com adEgemonye 46 Cancer Vaccines 46 Espicom 46 Crystallographic 46 Antigen CEA 46 Waters WAT 46 Inc Therapeutic Competitors 46 Oligonucleotides 46 Risk Reward 46 SWOT Profile 46 Lancets 45 Pharmacokinetic PK 45 Expandable Polystyrene 45 Analytical Tool 45 Ionic Liquids 45 Gene Expression Analysis 44 Insulin Delivery Systems 44 WWMR 44 Strategic Rationale 44 Competitive Analysis 44 Partnering Guide 44 Therapeutic Proteins 44 FAST Graphs ™ 44 Chartpoppers.com releases Investment 44 Histopathologic 44 Vascular Targeting 44 Myriad Genetics Inc 44 Oncology Compounds 44 Sagient 44 Reproductive Toxicology 44 pharmacoeconomic analysis 44 Wound Care Markets 44 CAS #-#-# Market [001] 43 Treatment Algorithms 43 Metabolomic 43 Novel Therapies 43 Wkly Tech 43 Predictive Toxicology 43 TERANODE 43 WikiWealth.com s 43 Analytical Biochemistry 43 Companion Diagnostics 43 SurModics SRDX 43 Clinical Trial Data 43 Clinical Outcome 43 DecisionBase 43 Synergyst 43 Gastrointestinal Stromal Tumors 43 IVGN 43 Genes Involved 43 Curidium 43 JAK Inhibitor 43 Protein Biomarker 43 Momenta Pharmaceuticals 43 Pipeline Analysis 42 Partneringreview 42 Qiagen NASDAQ QGEN 42 Nanopatterning 42 Gene Expression Profiling 42 Consolidation Continues 42 Aarkstore 42 Cystoscope 42 Allergan AGN 42 Pharmacodynamic 42 MLNM 42 Diagnostic Criteria 42 Integra Lifesciences 42 PESTLE 42 Topics Covered 42 Inc SWOT Framework 42 Updates FY# EPS 42 Partial Differential Equations 42 Nucleic Acids 42 Percutaneous Tibial Nerve Stimulation 42 Cardiotoxicity 42 Cancer Biomarkers 42 RGEN 42 Alnylam ALNY 41 Prognostic Value 41 PathFinderTG 41 Biogenerics 41 Molecular Diagnostic 41 Pharmacogenomic 41 Sector Detector 41 La Merie 41 Monoclonal Antibodies 41 Pharmacogenetic 41 anti dyslipidemic 41 Auxilium Pharma 41 xCELLigence System 41 5EU 41 Rsearch 41 Provides Detailed 41 Allergan NYSE AGN 41 Drug Pipeline 41 hERG 41 Adverse Event 41 N glycan 41 Key Competitors 41 PEST Analysis 41 Activity Assay 41 estrogen receptor modulators 41 Adverse Reactions 41 Handset Vendor 41 Package Insert 41 Wavelet 41 Isis Pharma 41 Momenta Pharmaceuticals MNTA 41 Multivariate 40 SectorCast 40 CardioVascular BioTherapeutics 40 Vertebral Fracture 40 Solubility 40 miRview meso 40 ViroPharma NASDAQ VPHM 40 Gets FDA Clearance 40 Backs FY# 40 Maven Semantic http:/www.mavensemantic.com announBruising Brandon 40 External Defibrillators 40 Mechanistic 40 Announce Collaboration Agreement 40 Biopharmaceutical Industry 40 URCH Publishing 40 Brand Positioning 40 Competitor Report 40 Atopic Dermatitis 40 Cannabinoid 40 Chemotherapeutic Agents 40 Antisense Pharma GmbH 40 QLTI 40 CYTR 40 Hepatic Encephalopathy 40 Targeted Therapeutics 40 Genomic Grade 40 Antifungals 40 Diastolic Heart Failure 40 Clinical Significance 40 Hypercholesterolemia 40 Content Outline 40 MOGN 40 EvaluatePharma 40 Navdeep Jaikaria 40 Particle Size Analyzer 40 Hepatocellular Carcinoma 40 DNAwithPap Test 40 Seattle Genetics SGEN 40 Dyslipidemia 40 Progenics Pharmaceuticals 40 Estrogen Receptor 40 Quantitative PCR 40 Pharmasset VRUS 40 Hormonal Contraceptives 40 NPS Pharma 40 Pharmaprojects 40 Dr. Siegall 39 Carotid Artery Stenting 39 ELISA kit 39 Mean Reversion 39 Cubist Pharmaceuticals CBST 39 Encysive Pharmaceuticals 39 Therapeutic Competitors Report 39 Pharmacoeconomic 39 Biomaterial 39 Xenoport Inc 39 TooNiceStocks 39 Nasdaq APPY 39 Investigational Compound 39 OSI Pharma 39 Tyrosine Kinase Inhibitor 39 NDQ 39 QSAR models 39 SPIVA 39 Dexcom 39 Lowers FY# EPS 39 Neurobiological 39 Protein Expression 39 categories Glucose Monitoring 39 Affirms FY# 39 Initiates Clinical Trial 39 Transdermal Delivery 39 biomolecular interactions 39 Datamonitors 39 Sanvar 39 Onyx Pharma 39 Schizophrenia Treatment 39 antithrombotic agents 39 Supernus Pharmaceuticals 39 Protein Therapeutics 39 peginterferon alpha 39 Therapeutic Areas 39 Idenix Pharmaceuticals 39 #:#-# [006] 39 Presents Positive Preclinical 39 polymorphs 39 Sirolimus eluting 38 Nasdaq IPXL 38 Momenta Pharma 38 NOVN 38 Migraine Drug 38 Inflammatory Disease 38 Insulin Glargine 38 ADME Tox 38 Lung Cancer Drug 38 Trandolapril 38 Treatment Algorithm 38 Pharmacor Patient Flow 38 See CLINICAL PHARMACOLOGY 38 Theranostics 38 Newsflow 38 Arqule 38 MEMY 38 AMEX AIS 38 Clinical Trials Review 38 INFI 38 uricase 38 protein biochip 38 Celgene Revlimid 38 Aspheric 38 Psychiatric Illness 38 Intravenous Equipment 38 Force Effectiveness 38 IMS MIDAS 38 & Sullivan http:/www.pharma.frost.com 38 Lovenox enoxaparin 38 DSM IV diagnoses 38 Alkeran 38 Initiates Clinical 38 Kinase Inhibitors 38 Benign Prostatic Hyperplasia 38 Qscan 38 Clarient Insight Dx 38 LEAD Therapeutics 38 Selenia Dimensions System 38 antithrombotics 38 teratogenicity 38 Cytokinetics CYTK 38 Pharmacokinetic Study 38 Protein Kinase Inhibitors 37 LeadDiscovery 37 Leerink Swan 37 pharmacodynamic parameters 37 Survey Conducted 37 human microdosing 37 pan HDAC inhibitor 37 DecisionSite 37 segment Biotest 37 iTRAQ 37 Licensing Agreements 37 Therapeutic Competitors Companies 37 Therapeutic Monoclonal Antibodies 37 Phase IIIB IV 37 Targeted Therapies 37 HDAC Inhibitor 37 Elagolix 37 Exelixis EXEL 37 Phase III Clinical Trials 37 Incs 37 Randomized Study 37 Myocardial Perfusion Imaging 37 Presents Preclinical 37 APPX 37 Tumor Targeting 37 Pharma Partnering 37 Teva TEVA 37 Risk Stratification 37 Neuroprotective Effects 37 Depomed DEPO 37 InVentiv 37 RAPAFLO TM silodosin 37 esreboxetine 37 Protelos R 37 Biosimilars 37 nCounter Analysis System 37 tubulin inhibitor 37 trastuzumab emtansine T DM1 37 Licenses Novel 37 Systemic Delivery 37 Impax Labs 37 Antibacterials 37 MedPredict 37 Nasdaq ACHN 37 NASDAQ ONXX 37 Clinical Trial Enrollment 37 Macro Trends 37 Gilead GILD 37 Pathway Diagnostics 37 NTIOL 37 Competitive Positioning 36 Carfilzomib 36 VentiRx Pharmaceuticals 36 preclinical efficacy 36 Heritability 36 Diasome 36 Enterix 36 IVIVC 36 Orally Disintegrating 36 sirtuin therapeutics 36 Targeted Therapy 36 Aureon 36 Mutational 36 FDA Approvals 36 Clinicaltrials.gov 36 Celera CRA 36 Submits NDA 36 Nasdaq IDRA today 36 NASDAQ OMER 36 Vernakalant 36 Bupropion XL 36 Preclinical Study 36 Protein Kinase 36 Cubist Pharma 36 Muraglitazar 36 GSK Advair 36 Taligen Therapeutics 36 Fibrin Patch 36 Mylan Nasdaq MYL 36 PGx 36 Bioenvision Nasdaq BIVN 36 Successfully Completes Phase 36 Externalization 36 Preclinical Models 36 IRX 36 Fingertip Formulary 36 Glatiramer acetate 36 Initiates Phase 2b 36 NASDAQ MYRX 36 Fragment Library 36 antidiabetics 36 Oral Insulin 36 Spatio Temporal 36 CNS Therapeutics 36 Adventrx Pharmaceuticals 36 Pharma Biotech 36 EquiTrend 36 Impax Laboratories Inc 36 RE SURGE 36 Genotypic 36 Salix Pharma 36 Bazedoxifene 36 SAS SPSS 36 Zoloft sertraline 36 Affymax AFFY 36 Correlogic 36 About BioCryst BioCryst 36 EXECUTIVE SUMMARY 36 Pharmacueticals 36 ASCO abstract 36 PDE inhibitors 36 MedChem 36 Schering SHR 36 Oxybutynin 36 Protease Inhibitors 36 Liquid chromatography 36 Sanofi NYSE SNY 36 Shows Efficacy 36 outlicensed 36 DOSAGE AND ADMINISTRATION 36 AstraZeneca Brilinta 36 MEVACOR 36 Anticancer Agents 36 Roopesh Patel 36 Study Shows Significant 36 Vascular Targeting Agents 35 Effexor venlafaxine 35 Drug Eluting Stents 35 PHARMACEUTICALS INC 35 Lupus Drug 35 Small Molecules 35 kinase profiling 35 Zometa zoledronic acid 35 Pharmaceuticals Initiates 35 Interferon alfa 35 thalidomide Thalomid 35 Neuroanatomy 35 BioSyent TSX VENTURE 35 Anticalin R 35 potency selectivity 35 Drug Interactions 35 Anticancer Agent 35 ONCONASE ranpirnase 35 Immunoassay Systems 35 Sector Rotation 35 BARI 2D 35 Erlotinib 35 glycopeptides 35 GIPET 35 BioMAP 35 miRBase 35 zoledronic acid Zometa 35 rxRNA 35 NRPH 35 Biotherapeutics 35 Retinal Vein Occlusion 35 Stakeholder Opinions 35 Prospective Multicenter 35 Quantifiable 35 Bioavailability 35 OPTIMIZE 35 peptidic 35 Homology 35 & Sullivan http:/www.healthcare.frost.com 35 Metabolic Profiling 35 Zybrestat 35 Gene Silencing 35 Key Findings 35 Angiolix 35 Genvec 35 Liquid Crystals 35 BiolineRX 35 RefSeq 35 Covance CVD 35 Therapeutic Antibodies 35 Files IND 35 Akesis Pharmaceuticals 35 Phenotypic 35 Small Molecule 35 Suicidality 35 AurSCOPE 35 nutrigenomic 35 Velcade bortezomib 35 Medicis Pharmaceutical Corp 35 Novel Therapeutic 35 Anti Infectives 35 Genentech Rituxan 35 Regulatory Submissions 35 nitric oxide donating prostaglandin 35 linear regressions 35 teriflunomide 35 Aptamer 35 ePharma Consumer ® 35 Commences Phase III 35 ACCORD Lipid 35 Present Preclinical Data 35 Interferon Alpha 35 Parathyroid Hormone 35 Antidiabetic 35 Vascular Wrap TM 35 Completes Patient Enrollment 35 Intellidex 35 XIENCE 35 clevidipine 35 phase IIIb 34 Rheumatoid Arthritis Drug 34 Aurora Kinase 34 Dealmaking Profile 34 Recombinant Human 34 Receives Milestone Payment 34 Cilostazol 34 seliciclib CYC# 34 Bioequivalence 34 Bayhill Therapeutics 34 Vitaxin 34 annexin 34 #Figure [003] 34 Penwest Pharma 34 Receives Approvable Letter 34 Analogs 34 Pertuzumab 34 #:#-# [001] 34 Orally Active 34 desvenlafaxine 34 Syllego system 34 Cheminformatics 34 Manoj Garg 34 Hydra Biosciences 34 Anti Tumor 34 isoform selective 34 BioMedTracker 34 Receptor Antagonists 34 Avanafil 34 Travatan 34 Immunotherapies 34 Drug Shows Promise 34 Flow Indicator 34 Percepta 34 EYET 34 GSK# [002] 34 Protein Structures 34 Technographics 34 Revatrol 34 PREVU x LT 34 Phase 2b monotherapy 34 FDA Okays 34 Maxygen MAXY 34 Nucleoside 34 Antiepileptic Drug 34 Presents Preclinical Data 34 CupPrint R 34 Growth Exceeds Expectations 34 PROactive Study 34 EMD Biosciences Inc. 34 oral diclofenac 34 Sustained Release 34 Daptomycin 34 gp# protein [002] 34 Darusentan 34 Presents Positive 34 SPPI 34 Guanilib 34 Achieves Primary Endpoint 34 APTIMA HPV assay 34 Product Monograph 34 Global Generics 34 Oxytrol R 34 Vascular Biogenics 34 neuronal nicotinic receptor NNR 34 Esomeprazole 34 novel oral anticoagulant 34 chemogenomic 34 Glycosylation 34 Consulting Fees Honoraria 34 Genedata Biologics 34 SAR# [002] 34 RECOTHROM R 34 Safinamide 34 prasugrel Effient 34 mGluR5 antagonists 34 Biomarker Study 34 Asthma COPD 34 Celldex Therapeutics CLDX 34 Disease Modification 33 SEQUEST 33 Nitrolingual 33 Inc. Nasdaq MLNM 33 Biomerk Tumorgrafts 33 PharMetrics 33 Psoriasis Drug 33 Tesmilifene 33 Emerging Markets EM 33 Immune Therapy 33 Osteoporosis Drug 33 phase IIb trial 33 Observational Study 33 TKPHF 33 hPTH #-# 33 Glatiramer Acetate 33 Epirubicin 33 Prospective Randomized 33 OraTest 33 Antisense Therapeutics 33 Tenthoff 33 Atypical Antipsychotics 33 Biovail BVF 33 Vaxfectin R 33 MDx 33 NSABP B 33 Niacinamide 33 Takeda Pharma 33 analyst Liana Moussatos 33 AcrySof 33 Neovastat 33 VeriStrat 33 SmPC 33 Solorel ® 33 Strattera atomoxetine 33 PROactive study 33 rEEG 33 Mitsubishi Tanabe 33 vildagliptin 33 NasalFent 33 PROMETHEUS 33 Tobira Therapeutics 33 Teva Pharm 33 Biomarin 33 Cancer Res 33 Medtronic Endeavor 33 Tufts CSDD 33 Aegerion Pharmaceuticals Inc. 33 Quadrix 33 HepaSphere 33 Nasdaq CELG 33 Avian Influenza Vaccine 33 Calcium Acetate 33 Ereska 33 Kevetrin ™ 33 Sporanox 33 Antipsychotic 33 Vimpat lacosamide 33 ELLIOTT WAVE 33 endophenotypes 33 Drug Fails 33 ROCKET AF 33 Demonstrates Potential 33 Angiotensin Converting Enzyme 33 Neurotherapeutics 33 PathVysion 33 AOD# [002] 33 Anti CD# Antibody 33 Prozac fluoxetine 33 YERVOY 33 RE LY trial 33 Zenvia Phase III 33 Pemetrexed 33 Moderate Complexity 33 atrasentan 33 SPIRIVA ® 33 Teva Pharma 33 Selective Serotonin Re 33 candidates Dyloject TM 33 SUTENT ® 33 Anacetrapib 32 Fulvestrant 32 PFIZER INC 32 observational cohort study 32 Cefzil 32 Oxcarbazepine 32 controlled multicenter Phase 32 Chemgenex 32 ZETIA ezetimibe 32 Onconase 32 gefitinib Iressa 32 SOLVAY PHARMACEUTICALS 32 Arthritis Drug 32 Anticancer Drug 32 Danazol 32 Trastuzumab DM1 32 peptidomimetic 32 Centocor Schering Plough 32 RE LY ® 32 serotonin norepinephrine reuptake inhibitor 32 Efficacy Study 32 Veregen 32 Sunovion 32 Orphan Diseases 32 GW# [003] 32 reboxetine 32 Transdermal Patch 32 NMEs 32 PREVU x 32 becocalcidiol 32 Verispan Vector One 32 humanized monoclonal 32 Inotek Pharmaceuticals Corporation 32 blood thinner Xarelto 32 InvestBio 32 PLAVIX ® 32 MetaCore TM 32 Valdoxan 32 Saftlas 32 Deforolimus 32 MoxDuo ® 32 Teva Pharmaceuticals Nasdaq TEVA 32 PRIALT 32 Ondansetron Orally Disintegrating Tablets 32 Levetiracetam 32 Holter Monitoring 32 AstraZeneca Toprol XL 32 Ambrisentan 32 proteasome inhibitor 32 Alexza Pharma 32 Sipuleucel T 32 ePharma Physician ® 32 Begins Clinical Trial 32 Insulins 32 Aposense 32 Wellbutrin Effexor 32 Biosimilar 32 PatientFinder 32 ITG Broker Edge 32 epoetin zeta 32 selective estrogen receptor modulator 32 Aegerion Pharmaceuticals 32 Vertex Pharmaceuticals Nasdaq VRTX 32 biomarker Septin 9 32 Interferon Alfa 32 ImClone Erbitux 32 XIENCE TM 32 Decision Biomarkers 32 Multicenter Phase 32 EMD Biosciences 32 Receptor Agonist 32 elotuzumab 32 monoclonal antibody mAb 32 antihormonal 32 Pazopanib 32 Roger Longman 32 pharma biotech 32 Cinacalcet HCl 32 Zemplar Capsules 32 Nasdaq SHPGY 32 selective adenosine 32 Escitalopram 32 PREDICTIVE 32 EGS# 31 Forest Labs FRX 31 Referenced EEG 31 Degarelix 31 DUROS 31 Actelion Pharmaceuticals Ltd 31 nanopharmaceutical 31 Osmotica 31 Vidaza azacitidine 31 Bristol Myers Squibb Sprycel 31 Merck Januvia 31 Orazol 31 FRESENIUS 31 RezularTM 31 Iloperidone 31 Vildagliptin 31 PPAR gamma agonists 31 Novartis Gilenya 31 Shionogi Pharma 31 Small Molecule Drug 31 ZOCOR 31 L BLP# 31 Novel Inhibitor 31 Receives Orphan Drug 31 ILLUSTRATE 31 Ridaforolimus 31 AssureRx 31 Pexeva 31 Huntexil 31 ANCOVA 31 SYN X 31 Felodipine 31 Anti infective 31 ASTEROID 31 MarketScan 31 Omacor ® 31 Amlodipine Besylate 31 Glucophage XR 31 Valsartan 31 Andrx ADRX 31 Olmesartan 31 Oglemilast 31 Rebif ® 31 Weight Loss Drug 31 Temsirolimus 31 BrainCells 31 RESOLOR 31 etanercept Enbrel 31 Genetech 31 Aflibercept 31 Kinase Inhibitor 31 Androgel R 30 Extends Collaboration 30 Betaferon R 30 VIVUS Qnexa 30 Sanofi Aventis Taxotere 30 Nasdaq CRTX 30 RE LY 30 Topoisomerase 30 Dendreon Provenge 30 Lucanix 30 Vivecon 30 Gilead Sciences Nasdaq GILD 30 Leflunomide 30 Evoltra 30 Bx Velocity 30 Venlafaxine 30 synthetic siRNA 30 Prolexys 30 CB1 antagonists 30 regorafenib 30 Akebia Therapeutics 30 AM Vitals 30 CNS Disorders 30 Zetia Vytorin 30 Celexa citalopram 30 Acurox r Tablets 30 Lyrica pregabalin 30 Fluconazole 30 antiplatelets 30 Sapacitabine 30 NanoCrystal 30 Omnicare Clinical Research 30 ICON7 30 ONCOLOGY 30 Milnacipran 30 TRANSFORMS 30 Betaferon multiple sclerosis 30 Ticagrelor 30 GlaxoSmithKline Imitrex 30 generic Copaxone 30 Ascenta Therapeutics 30 Alexion Soliris 30 OPAXIO TM 30 NSCLC tumors 30 Boehringer Ingelheim Pharma 30 Bucindolol 30 Astex 30 BiTE 30 JAK inhibitor 30 Multiple Ascending Dose 30 Oxymorphone ER 30 motesanib diphosphate 30 Eli Lilly Cymbalta 30 Initiates Phase III 30 Genentech Roche Chugai 30 small molecule modulators 30 Ziprasidone 30 Vectibix panitumumab 30 Finacea 30 VR1 29 Aciphex R 29 GlaxoSmithKline Coreg 29 Phase IIA 29 Pfizer Lipitor atorvastatin 29 unbranded generics 29 insulin glargine Lantus 29 transdermal formulation 29 DepoMed 29 PHARMACEUTICALS 29 Arisaph 29 Conjugate 29 UCB Cimzia 29 OvaRex R 29 adenosine injection 29 Degludec 29 Epoetin 29 HORIZONS AMI 29 Nereus Pharmaceuticals 29 R Bambuterol 29 clopidogrel bisulfate 29 receptor modulators 29 glucokinase activator 29 SGLT 2 29 beta interferons 29 Maxalt 29 ANTEGREN 29 NN# [001] 29 Vernalis plc 29 Organon Pharmaceuticals 29 Wyeth Effexor XR 29 Inhibitors 29 PTK# 29 Stapled Peptide 29 MEDai Risk 29 orally disintegrating 29 PEGylated interferon 29 Ultracet R 28 KAI Pharmaceuticals 28 BRILINTA 28 PROTONIX 28 CALGB 28 J Cardiovasc 28 Ortho Cept 28 Glaxo GSK 28 Amide 28 Cymbalta duloxetine 28 oral renin inhibitor 28 Seroquel quetiapine 28 pharmacokinetic PK study 28 DAYTRANA TM 28 BioResearch 28 PARP Inhibitor 28 Enanta 28 Cognition Therapeutics 28 UCB Keppra 28 Valuation Model 28 everolimus eluting 28 biopharma 28 Bayer Yakuhin 28 NK1 28 Glaxosmithkline Plc 28 pharmacophore 28 multicenter Phase II 28 oral treprostinil 28 AstraZeneca AZN.ISE 28 Intendis 28 Marqibo TM 28 Treanda 28 PRX 28 glatiramer 28 Celgene Thalomid 28 Tamsulosin 28 Humira adalimumab 28 Biogen Elan 28 GEMS TM 28 Januvia sitagliptin 28 Toyo Bio 28 Locus Pharmaceuticals 27 SuperAntibody 27 Sandoz Novartis 27 oral dnaJP1 27 xenograft mouse 27 Locked Nucleic Acid LNA 27 BMS # 27 Generics 27 SMIP 27 GastroPlus TM 27 AstraZeneca Targacept 27 GlaxoSmithKline Requip 27 PEG IFN 27 Glaxo SmithKline GSK 27 DCCR 27 Copaxone Teva 27 Omnitarg 27 HIV integrase inhibitor 27 Tamsulosin capsules 27 Stalevo ® 27 Boniva ibandronate 27 PDE4 inhibitor 27 CATG 27 Novartis Gleevec 27 CureDM 27 Adenoscan R 27 CSL CSL 27 staphylococcal vaccine 27 Biogen IDEC 27 lovastatin Mevacor 27 enoxaparin sodium injection 27 GlaxoSmithKline Lamictal 27 Plavix R Iscover 27 Topiramate Tablets 27 Febuxostat 27 Aplenzin 27 Smith Kline Beecham 27 Zocor Zetia 27 Epothilone 26 LUMINATE 26 Cladribine 26 GlaxoSmithKline Wellbutrin 26 Aileron Therapeutics 26 Sequenced Treatment Alternatives 26 BIOTECH STOCKS 26 Extended Release tablets 26 RELOVAIR ™ 26 Synavive ™ 26 basal insulin analogue 26 Roche Pegasys 26 biosimilar versions 26 efavirenz EFV 26 Enjuvia 26 Cipralex 26 Lipitor Plavix 26 BioPharma 26 Calbiochem 26 Pharma 26 AstraZeneca Toprol 26 Atelvia 26 Forteo teriparatide 26 Extavia 26 Sertraline 26 DR Tablets 26 Merck MRK Pfizer PFE 25 Sepracor Lunesta 25 Tenormin 25 Hematide ™ peginesatide 25 recombinant insulin 25 Vilazodone 25 Actonel risedronate 25 BLP# 25 ENDEAVOR 25 Roche Boniva 25 Genzyme Myozyme 25 PhiloGene 25 sitagliptin Januvia 25 serotonin reuptake inhibitor 25 multicenter multinational 25 pregabalin Lyrica 25 vemurafenib 25 mAb 25 Focalin XR R 25 pharma 25 NYSE WYE 25 OrCel R Cellular 25 Xience Prime 25 pharmaco 25 Stedesa 24 Entocort EC 24 Pfizer Camptosar 24 Xarelto rivaroxaban 24 Biogen Idec Elan 24 Amplimmune 24 Teva Nasdaq TEVA 24 Initiated Phase 24 Pooled Funds 23 Avastin Herceptin 23 Tiazac 23 generic Allegra 23 RADIANCE 23 biobetter 22 PF # [002] 22 Biogen Tysabri 22 Avonex interferon beta 1a 22 Premarin Prempro 22 Pharmas 21 Fosamax alendronate 21 pharmas 21 @ FierceBiotech 21 Expenditure Forecast 20 COLAL PRED 20 inlicensing 19 Nebivolol